These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11901033)

  • 1. Oral anticoagulation for acute coronary syndromes.
    Brouwer MA; Verheugt FW
    Circulation; 2002 Mar; 105(11):1270-4. PubMed ID: 11901033
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting.
    Pipilis A; Lazaros G; Tsakonas G; Stefanadis C
    Hellenic J Cardiol; 2010; 51(4):330-7. PubMed ID: 20650831
    [No Abstract]   [Full Text] [Related]  

  • 3. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
    Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
    Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
    Wallén H; Agren A; Nekludov M
    Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
    [No Abstract]   [Full Text] [Related]  

  • 5. When should ACE inhibitors or warfarin be discontinued after myocardial infarction?
    Wiegers SE; St John Sutton M
    Heart; 2000 Oct; 84(4):361-2. PubMed ID: 10995398
    [No Abstract]   [Full Text] [Related]  

  • 6. Early and late outcomes of clopidogrel and coumadin combination for patients on oral anticoagulants undergoing coronary stenting.
    Ait Mokhtar O; Bonello L; Armero S; Sbragia P; Paganelli F
    Cardiovasc Revasc Med; 2010; 11(3):159-62. PubMed ID: 20599166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy.
    Tanguay JF; Bell AD; Ackman ML; Bauer RD; Cartier R; Chan WS; Douketis J; Roussin A; Schnell G; Verma S; Wong G; Mehta SR;
    Can J Cardiol; 2013 Nov; 29(11):1334-45. PubMed ID: 23978596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
    Buresly K; Eisenberg MJ; Zhang X; Pilote L
    Arch Intern Med; 2005 Apr; 165(7):784-9. PubMed ID: 15824298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less benefit from warfarin in diabetics after myocardial infarction?
    Smith PJ; Hurlen M; Abdelnoor M; Arnesen H
    Cardiology; 2008; 111(3):161-6. PubMed ID: 18434719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment: Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Friesen M
    Ann Pharmacother; 2008 Oct; 42(10):1521; author reply 1521. PubMed ID: 18765833
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
    Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
    Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications.
    ten Berg JM; Hutten BA; Kelder JC; Verheugt FW; Plokker HW
    Circulation; 2001 Apr; 103(16):2042-7. PubMed ID: 11319192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).
    Healey JS; Hart RG; Pogue J; Pfeffer MA; Hohnloser SH; De Caterina R; Flaker G; Yusuf S; Connolly SJ
    Stroke; 2008 May; 39(5):1482-6. PubMed ID: 18323500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Warfarin combined with blood platelet inhibition].
    Vik-Mo H
    Tidsskr Nor Laegeforen; 2011 Feb; 131(3):252-3. PubMed ID: 21304575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation.
    Gao F; Zhou YJ; Wang ZJ; Yang SW; Nie B; Liu XL; Jia de A; Yan ZX
    Int J Cardiol; 2011 Apr; 148(1):96-101. PubMed ID: 21185095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
    Faza NN; Mentias A; Parashar A; Chaudhury P; Barakat AF; Agarwal S; Wayangankar S; Ellis SG; Murat Tuzcu E; Kapadia SR
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):E64-E74. PubMed ID: 27220088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
    Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
    Lincoff AM; Steinhubl SR; Manoukian SV; Chew D; Pollack CV; Feit F; Ware JH; Bertrand ME; Ohman EM; Desmet W; Cox DA; Mehran R; Stone GW;
    JACC Cardiovasc Interv; 2008 Dec; 1(6):639-48. PubMed ID: 19463378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.